Our fellowship-trained medical and radiation oncologists, surgeons and speech and swallow therapists work together to support each patient’s experience. New patients can meet all of our experts through a weekly multidisciplinary clinic and have access to clinical trials. Our experts participate in a weekly tumor board conference to discuss new patient cases with additional head and neck cancer experts at our main campus in East Baltimore. Each patient participates in forming an individualized care plan that maximizes the opportunity for a successful outcome.
Some salivary gland tumors can express molecular markers like the receptors for androgen (usually seen in prostate cancers) or human epidermal growth factor-2, or HER-2 (usually seen in breast cancers). Patients with these tumors may be good candidates for hormone therapies.
Some cancers may benefit from proton therapy, which uses high energy beams to deliver radiation. The Johns Hopkins Proton Therapy Center at Sibley Memorial Hospital is one of the largest and most advanced centers in the U.S.